F. Caux

8.2k total citations
92 papers, 2.7k citations indexed

About

F. Caux is a scholar working on Pathology and Forensic Medicine, Genetics and Rheumatology. According to data from OpenAlex, F. Caux has authored 92 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pathology and Forensic Medicine, 39 papers in Genetics and 32 papers in Rheumatology. Recurrent topics in F. Caux's work include Autoimmune Bullous Skin Diseases (55 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (34 papers) and Urticaria and Related Conditions (29 papers). F. Caux is often cited by papers focused on Autoimmune Bullous Skin Diseases (55 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (34 papers) and Urticaria and Related Conditions (29 papers). F. Caux collaborates with scholars based in France, United States and Australia. F. Caux's co-authors include L. Laroche, C. Prost‐Squarcioni, Detlef Zillikens, Luis A. Díaz, George J. Giudice, José M. Mascaró, M. Alexandre, Michel Longy, B. Bouadjar and Florence Jobard and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Ophthalmology.

In The Last Decade

F. Caux

89 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Caux France 27 1.4k 1.0k 966 684 241 92 2.7k
Pearlie K. Epling‐Burnette United States 34 718 0.5× 1.2k 1.2× 215 0.2× 1.2k 1.7× 19 0.1× 113 4.0k
Yasufumi Masaki Japan 26 707 0.5× 382 0.4× 918 1.0× 411 0.6× 11 0.0× 115 2.6k
Masaharu Sakurai Japan 27 286 0.2× 486 0.5× 69 0.1× 1.0k 1.5× 90 0.4× 66 2.6k
Ruth I. Brezinschek United States 24 485 0.3× 395 0.4× 261 0.3× 590 0.9× 12 0.0× 38 2.5k
Barbara White United States 23 650 0.5× 79 0.1× 734 0.8× 454 0.7× 14 0.1× 50 2.5k
Yoshio Kanayama Japan 25 240 0.2× 403 0.4× 464 0.5× 946 1.4× 9 0.0× 78 3.1k
Nobuhiro Tsukada Japan 20 458 0.3× 1.2k 1.2× 118 0.1× 750 1.1× 24 0.1× 140 2.9k
Zhi Liu United States 32 2.4k 1.7× 2.0k 2.0× 1.8k 1.9× 513 0.8× 3 0.0× 88 3.9k
Tamihiro Kawakami Japan 26 765 0.5× 388 0.4× 735 0.8× 484 0.7× 3 0.0× 126 2.4k
Arnold S. Kirshenbaum United States 23 203 0.1× 265 0.3× 780 0.8× 626 0.9× 14 0.1× 44 2.9k

Countries citing papers authored by F. Caux

Since Specialization
Citations

This map shows the geographic impact of F. Caux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Caux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Caux more than expected).

Fields of papers citing papers by F. Caux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Caux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Caux. The network helps show where F. Caux may publish in the future.

Co-authorship network of co-authors of F. Caux

This figure shows the co-authorship network connecting the top 25 collaborators of F. Caux. A scholar is included among the top collaborators of F. Caux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Caux. F. Caux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Murrell, Dédée F., F. Caux, Aikaterini Patsatsi, et al.. (2024). Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS Phase 3 Randomized Study. Journal of Investigative Dermatology. 144(8). 1762–1771.e6. 7 indexed citations
3.
Tancrède‐Bohin, Emmanuelle, M. Alexandre, S. Oro, et al.. (2023). Efficacy and safety of anti-COVID-19 vaccination in patients with autoimmune blistering diseases: A French national study. Journal of the American Academy of Dermatology. 90(1). 204–208. 2 indexed citations
4.
Gillibert, André, S. Duvert‐Lehembre, M. Alexandre, et al.. (2020). Sensitivity to change and correlation between the autoimmune bullous disease quality‐of‐life questionnaires ABQOL and TABQOL , and objective severity scores. British Journal of Dermatology. 183(5). 944–945. 8 indexed citations
5.
Bohelay, G., F. Caux, & Philippe Musette. (2020). Clinical and Biological Activity of Rituximab in the Treatment of Pemphigus. Immunotherapy. 13(1). 35–53. 5 indexed citations
6.
Izri, Arezki, Typhaine Billard‐Pomares, Théo Ghelfenstein-Ferreira, et al.. (2020). Molecular identification of Actinomadura madurae isolated from a patient originally from Algeria; observations from a case report. BMC Infectious Diseases. 20(1). 829–829. 4 indexed citations
7.
Rousseau, Antoine, C. Prost‐Squarcioni, Serge Doan, et al.. (2019). Ocular involvement in epidermolysis bullosa acquisita with long-term follow-up. British Journal of Ophthalmology. 104(2). 235–240. 7 indexed citations
8.
Yatim, Ahmad, G. Bohelay, S. Grootenboer‐Mignot, et al.. (2019). Paraneoplastic Pemphigus Revealed by Anti-programmed Death-1 Pembrolizumab Therapy for Cutaneous Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa. Frontiers in Medicine. 6. 249–249. 19 indexed citations
9.
Prost‐Squarcioni, C., F. Tétart, Benoît Bensaïd, et al.. (2018). Drug‐induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases. British Journal of Clinical Pharmacology. 85(3). 570–579. 39 indexed citations
10.
Prost‐Squarcioni, C., F. Caux, Enno Schmidt, et al.. (2017). International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita. British Journal of Dermatology. 179(1). 30–41. 45 indexed citations
11.
Gottlieb, J., S. Oro, M. Alexandre, et al.. (2016). Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults. British Journal of Dermatology. 177(1). 212–222. 34 indexed citations
12.
Roux‐Villet, C. Le, Pascale Loiseau, Marc Busson, et al.. (2011). Black Patients of African Descent and HLA-DRB1*15:03 Frequency Overrepresented in Epidermolysis Bullosa Acquisita. Journal of Investigative Dermatology. 131(12). 2386–2393. 57 indexed citations
13.
Doan, Serge, et al.. (2006). Rituximab in Severe Ocular Cicatricial Pemphigoid. Investigative Ophthalmology & Visual Science. 47(13). 594–594. 1 indexed citations
14.
Alexandre, M., Marie-Dominique Brette, Francis Pascal, et al.. (2006). A Prospective Study of Upper Aerodigestive Tract Manifestations of Mucous Membrane Pemphigoid. Medicine. 85(4). 239–252. 42 indexed citations
15.
Lok, Catherine, M.-F. Avril, M.‐A. Richard, et al.. (2005). Brain Magnetic Resonance Imaging in Patients With Cowden Syndrome. Medicine. 84(2). 129–136. 72 indexed citations
16.
Joly, P., Jacques Bénichou, Catherine Lok, et al.. (2005). Prediction of Survival for Patients With Bullous Pemphigoid. Archives of Dermatology. 141(6). 691–8. 109 indexed citations
17.
Lefèvre, Caroline, Florence Jobard, F. Caux, et al.. (2001). Mutations in CGI-58, the Gene Encoding a New Protein of the Esterase/Lipase/Thioesterase Subfamily, in Chanarin-Dorfman Syndrome. The American Journal of Human Genetics. 69(5). 1002–1012. 346 indexed citations
18.
Bédane, C., Cathérine Prost, E Thomine, et al.. (1996). Binding of autoantibodies is not restricted to desmosomes in pemphigus vulgaris:. Archives of Dermatological Research. 288(7). 343–352. 27 indexed citations
19.
Caux, F., S. Aractingi, H. Baurmann, et al.. (1993). <i>Fusarium solani</i> Cutaneous Infection in a Neutropenic Patient. Dermatology. 186(3). 232–235. 19 indexed citations
20.
Caux, F., József Tı́már, E. Móczár, K. Lapis, & M Moczar. (1990). Cell-associated glycosaminoglycans in human melanoma cell culture. Biochemical Society Transactions. 18(2). 294–295. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pearlie K. Epling‐Burnette Breakdown of academic impact, for papers by Yasufumi Masaki Breakdown of academic impact, for papers by Masaharu Sakurai Breakdown of academic impact, for papers by Ruth I. Brezinschek Breakdown of academic impact, for papers by Barbara White Breakdown of academic impact, for papers by Yoshio Kanayama Breakdown of academic impact, for papers by Nobuhiro Tsukada Breakdown of academic impact, for papers by Zhi Liu Breakdown of academic impact, for papers by Tamihiro Kawakami Breakdown of academic impact, for papers by Arnold S. Kirshenbaum
Rankless by CCL
2026